| Each uncoated tablet contains : |
|
|
| Diclofenac Sodium |
I.P. |
50 mg |
| Paracetamol |
I.P. |
325 mg |
| Excipients |
|
q.s. |
| 127 |
Tablets |
Amlodipine Besylate and Metoprolol Succinate (ER)Tablets |
| Composition |
Standard |
Quantity |
| Each uncoated tablet contains : |
|
|
| Amlodipine Besylate (Eq. to Amlodipine) |
I.P. |
5 mg |
| Metoprolol Succinate (eq. to Metoprolol Tartrate, Extended Released) |
I.P. |
47.5 mg (50 mg eq.) |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 128 |
Tablets |
Amlodipine Besilate and Atenolol Tablets I.P. |
| Composition |
Standard |
Quantity |
| Each uncoated tablet contains : |
|
|
| Amlodipine Besilate (eq. to Amlodipine) |
I.P. |
5 mg |
| Atenolol |
I.P. |
50 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 129 |
Tablets |
Amlodipine Besilate Tablets I.P. |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains : |
|
|
| Amlodipine Besilate (eq. to Amlodipine) |
I.P. |
5 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 130 |
Tablets |
Metformin Hydrochloride Sustained Released Tablets I.P. |
| Composition |
Standard |
Quantity |
| Each uncoated tablet contains : |
|
|
| Metformin Hydrochloride (sustained released) |
I.P. |
500 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 131 |
Tablets |
Losartan Potassium and Hydrochlorothiazide Tablets I.P. |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains : |
|
|
| Losartan Potassium |
I.P. |
50 mg |
| Hydrochlorothiazide |
I.P. |
12.5 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 132 |
Tablets |
Losartan Potassium and Amlodipine Tablets I.P. |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains : |
|
|
| Losartan Potassium |
I.P. |
50 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 133 |
Tablets |
Losartan Potassium Tablets I.P. 50 mg |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains : |
|
|
| Losartan Potassium |
I.P. |
50 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 134 |
Tablets |
Linezolid Tablets I.P. |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains : |
|
|
| Linezolid |
I.P. |
600 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 135 |
Tablets |
Olmesartan Medoxomil and Amlodipine Tablets |
| Composition |
Standard |
Quantity |
| Each uncoated tablet contains : |
|
|
| Olmesartan Medoxomil |
I.P. |
40 mg |
| Amlodipine Besylate (eq. to Amlodipine) |
I.P. |
5 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 136 |
Tablets |
Olmesartan Medoxomil 20 mg and Hydrochlorothiazide 12.5 mg Tablets I.P |
| Composition |
Standard |
Quantity |
| Each uncoated tablet contains : |
|
|
| Olmesartan Medoxomil |
I.P. |
20 mg |
| Hydrochlorothiazide |
I.P. |
12.5 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 137 |
Tablets |
Olmesartan Medoxomil Tablets I.P. 40 mg |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains : |
|
|
| Olmesartan Medoxomil |
I.P. |
40 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 138 |
Tablets |
Olmesartan Medoxomil Tablets I.P. 20 mg |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains : |
|
|
| Olmesartan Medoxomil |
I.P. |
20 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 139 |
Tablets |
Loratadine Tablets I.P. |
| Composition |
Standard |
Quantity |
| Each uncoated tablet contains : |
|
|
| Loratadine |
I.P. |
10 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 140 |
Tablets |
Citicoline Tablets I.P 500 mg |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains : |
|
|
| Citicoline Sodium (eq. to Citicoline) |
I.P. |
500 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 141 |
Tablets |
Hydroxyzine Tablets I.P. 25 mg |
| Composition |
Standard |
Quantity |
| Each uncoated tablet contains : |
|
|
| Hydroxyzine Hydrochloride |
I.P. |
25 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 142 |
Tablets |
Hydroxyzine Tablets I.P. 10 mg |
| Composition |
Standard |
Quantity |
| Each uncoated tablet contains : |
|
|
| Hydroxyzine Hydrochloride |
I.P. |
10 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 143 |
Tablets |
Voglibose Tablets I.P. 0.3 mg |
| Composition |
Standard |
Quantity |
| Each uncoated tablet contains : |
|
|
| Voglibose |
I.P. |
0.3 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 144 |
Tablets |
Voglibose Tablets I.P. 0.2 mg |
| Composition |
Standard |
Quantity |
| Each uncoated tablet contains : |
|
|
| Voglibose |
I.P. |
0.2 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 145 |
Tablets |
Febuxostat Tablets 80 mg |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains : |
|
|
| Febuxostat |
|
80 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 146 |
Tablets |
Febuxostat Tablets 40 mg |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains : |
|
|
| Febuxostat |
|
40 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 147 |
Tablets |
Serratiopeptidase Tablets I.P. 10 mg |
| Composition |
Standard |
Quantity |
| Each enteric coated tablet contains : |
|
|
| Serratiopeptidase (as enteric coated granules eq. to enzymatic activity 20,000 units) |
I.P. |
10 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 148 |
Tablets |
Paracetamol Tablets I.P. 650 mg |
| Composition |
Standard |
Quantity |
| Each uncoated tablet contains : |
|
|
| Paracetamol |
I.P. |
650 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 149 |
Tablets |
Betahistine Hydrochloride Tablets I.P. |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains : |
|
|
| Betahistine Hydrochloride |
I.P. |
8 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 150 |
Tablets |
Betahistine Hydrochloride Tablets I.P. |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains : |
|
|
| Betahistine Hydrochloride |
I.P. |
16 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 151 |
Tablets |
Levocetirizine Tablets I.P. 5 mg |
| Composition |
Standard |
Quantity |
| Each uncoated tablet contains : |
|
|
| Levocetirizine Hydrochloride |
I.P. |
5 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 152 |
Tablets |
Cetirizine Hydrochloride Tablets I.P. 10 mg |
| Composition |
Standard |
Quantity |
| Each uncoated tablet contains : |
|
|
| Cetirizine Hydrochloride |
I.P. |
10 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 153 |
Tablets |
Pantoprazole Gastro-resistant Tablets I.P. 40 mg |
| Composition |
Standard |
Quantity |
| Each enteric-coated tablet contains : |
|
|
| Pantoprazole Sodium eq. to Pantoprazole |
I.P. |
40 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 154 |
Tablets |
Divalproex Extended Release Tablets I.P 1000mg |
| Composition |
Standard |
Quantity |
| Each film-coated extended-release tablet contains : |
|
|
| Divalproex Sodium eq. to Valproic Acid |
I.P. |
1000 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 155 |
Tablets |
Divalproex Extended Release Tablets I.P 500mg |
| Composition |
Standard |
Quantity |
| Each film-coated extended-release tablet contains : |
|
|
| Divalproex Sodium eq. to Valproic Acid |
I.P. |
500 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 156 |
Tablets |
Divalproex Extended Release Tablets I.P 250mg |
| Composition |
Standard |
Quantity |
| Each film-coated extended-release tablet contains : |
|
|
| Divalproex Sodium eq. to Valproic Acid |
I.P. |
250 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 157 |
Tablets |
Telmisartan, Amlodipine and Hydrochlorothiazide Tablets |
| Composition |
Standard |
Quantity |
| Each uncoated tablet contains : |
|
|
| Telmisartan |
I.P. |
40 mg |
| Amlodipine Besylate eq. to Amlodipine |
I.P. |
5 mg |
| Hydrochlorothiazide |
I.P. |
12.5 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 158 |
Tablets |
Telmisartan 80 mg and Hydrochlorothiazide 12.5 mg Tablets I.P |
| Composition |
Standard |
Quantity |
| Each film-coated tablet contains : |
|
|
| Telmisartan |
I.P. |
80 mg |
| Hydrochlorothiazide |
I.P. |
12.5 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 159 |
Tablets |
Telmisartan 40 mg and Hydrochlorothiazide 12.5 mg Tablets I.P. |
| Composition |
Standard |
Quantity |
| Each film-coated tablet contains : |
|
|
| Telmisartan |
I.P. |
40 mg |
| Hydrochlorothiazide |
I.P. |
12.5 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 160 |
Tablets |
Telmisartan Tablets I.P. 80 mg |
| Composition |
Standard |
Quantity |
| Each uncoated tablet contains : |
|
|
| Telmisartan |
I.P. |
80 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 161 |
Tablets |
Telmisartan Tablets I.P. 40 mg |
| Composition |
Standard |
Quantity |
| Each uncoated tablet contains : |
|
|
| Telmisartan |
I.P. |
40 mg |
| Excipients |
q.s. |
|
| Approved Colour used |
|
|
|
| 162 |
Tablets |
Telmisartan Tablets I.P. 20 mg |
| Composition |
Standard |
Quantity |
| Each uncoated tablet contains : |
|
|
| Telmisartan |
I.P. |
20 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 163 |
Tablets |
Duloxetine Hydrochloride Tablets 30 mg |
| Composition |
Standard |
Quantity |
| Each enteric-coated tablet contains : |
|
|
| Duloxetine Hydrochloride eq. to Duloxetine |
I.P. |
30 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 164 |
Tablets |
Duloxetine Hydrochloride Tablets 20mg |
| Composition |
Standard |
Quantity |
| Each enteric-coated tablet contains : |
|
|
| Duloxetine Hydrochloride eq. to Duloxetine |
I.P. |
20 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 165 |
Tablets |
Rosuvastatin Calcium and Fenofibrate Tablets |
| Composition |
Standard |
Quantity |
| Each film-coated tablet contains : |
|
|
| Rosuvastatin Calcium eq. to Rosuvastatin |
I.P. |
10 mg |
| Fenofibrate |
I.P. |
160 mg |
| Excipients |
|
q.s. |
| Colour |
|
|
|
| 166 |
Tablets |
Rosuvastatin Calcium Tablets I.P. 20 mg |
| Composition |
Standard |
Quantity |
| Each film-coated tablet contains : |
|
|
| Rosuvastatin Calcium eq. to Rosuvastatin |
I.P. |
20 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 167 |
Tablets |
Rosuvastatin Calcium Tablets I.P. 10 mg |
| Composition |
Standard |
Quantity |
| Each film-coated tablet contains : |
|
|
| Rosuvastatin Calcium eq. to Rosuvastatin |
I.P. |
10 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 168 |
Tablets |
Rosuvastatin Calcium Tablets I.P. 5 mg |
| Composition |
Standard |
Quantity |
| Each film-coated tablet contains : |
|
|
| Rosuvastatin Calcium eq. to Rosuvastatin |
I.P. |
5 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 169 |
Tablets |
Methylprednisolone Tablets I.P. 16 mg |
| Composition |
Standard |
Quantity |
| Each uncoated tablet contains : |
|
|
| Methylprednisolone |
I.P. |
16 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 170 |
Tablets |
Methylprednisolone Tablets 8 mg |
| Composition |
Standard |
Quantity |
| Each uncoated tablet contains : |
|
|
| Methylprednisolone |
I.P. |
8 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 171 |
Tablets |
Methylprednisolone Tablets I.P. 4 mg |
| Composition |
Standard |
Quantity |
| Each uncoated tablet contains : |
|
|
| Methylprednisolone |
I.P. |
4 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 172 |
Tablets |
Atenolol Tablets I.P. 100 mg |
| Composition |
Standard |
Quantity |
| Each uncoated tablet contains : |
|
|
| Atenolol |
I.P. |
100 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 173 |
Tablets |
Atenolol Tablets I.P. 50 mg |
| Composition |
Standard |
Quantity |
| Each uncoated tablet contains : |
|
|
| Atenolol |
I.P. |
50 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 174 |
Tablets |
Atorvastatin Calcium and Fenofibrate Tablets |
| Composition |
Standard |
Quantity |
| Each film-coated tablet contains : |
|
|
| Atorvastatin Calcium eq. to Atorvastatin |
I.P. |
10 mg |
| Fenofibrate |
I.P. |
160 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 175 |
Tablets |
Atorvastatin Tablets I.P. 40 mg |
| Composition |
Standard |
Quantity |
| Each film-coated tablet contains : |
|
|
| Atorvastatin Calcium eq. to Atorvastatin |
I.P. |
40 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 176 |
Tablets |
Atorvastatin Tablets I.P. 20 mg |
| Composition |
Standard |
Quantity |
| Each film-coated tablet contains : |
|
|
| Atorvastatin Calcium eq. to Atorvastatin |
I.P. |
20 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 177 |
Tablets |
Atorvastatin Tablets I.P. 10 mg |
| Composition |
Standard |
Quantity |
| Each film-coated tablet contains : |
|
|
| Atorvastatin Calcium eq. to Atorvastatin |
I.P. |
10 mg |
| Excipients |
|
q.s. |
| Approved Colour used |
|
|
|
| 178 |
Tablets |
Fexofenadine and Montelukast Tablets |
| Composition |
Standard |
Quantity |
| Each chewable film-coated tablet contains : |
|
|
| Fexofenadine Hydrochloride |
I.P. |
120 mg |
| Montelukast Sodium eq. to Montelukast |
I.P. |
10 mg |
| Excipients |
q.s. |
|
| Approved Colour used |
|
|
|
| 179 |
Tablets |
Fexofenadine Hydrochloride Tablets I.P. 180 mg |
| Composition |
Standard |
Quantity |
| Each film-coated tablet contains : |
|
|
| Fexofenadine Hydrochloride |
I.P. |
180 mg |
| Excipients |
q.s. |
|
| Approved Colour used |
|
|
|
| 180 |
Tablets |
Fexofenadine Hydrochloride Tablets I.P. 120 mg |
| Composition |
Standard |
Quantity |
| Each film-coated tablet contains : |
|
|
| Fexofenadine Hydrochloride |
I.P. |
120 mg |
| Excipients |
q.s. |
|
| Approved Colour used |
|
|
|
| 181 |
Tablets |
Escitalopram Tablets I.P 20 mg |
| Composition |
Standard |
Quantity |
| Each film-coated tablet contains : |
|
|
| Escitalopram Oxalate eq. to Escitalopram |
I.P. |
20 mg |
| Excipients |
q.s. |
|
| Approved Colour used |
|
|
|
| 182 |
Tablets |
Escitalopram Tablets I.P 10 mg |
| Composition |
Standard |
Quantity |
| Each film-coated tablet contains : |
|
|
| Escitalopram Oxalate eq. to Escitalopram |
I.P. |
10 mg |
| Excipients |
q.s. |
|
| Approved Colour used |
|
|
|
| 183 |
Tablets |
Escitalopram Tablets I.P 5 mg |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains : |
|
|
Escitalopram Oxalate (eq. to Escitalopram) |
I.P. |
5 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 184 |
Tablets |
Etoricoxib Tablets I.P 120 mg |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains : |
|
|
| Etoricoxib |
I.P. |
120 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 185 |
Tablets |
Etoricoxib Tablets I.P 90 mg |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains : |
|
|
| Etoricoxib |
I.P. |
90 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 186 |
Tablets |
Etoricoxib Tablets I.P 60 mg |
| Composition |
Standard |
Quantity |
| Each film-coated tablet contains : |
|
|
| Etoricoxib |
I.P. |
60 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 187 |
Tablets |
Ondansetron Orally Disintegrating Tablets I.P. 8 mg |
| Composition |
Standard |
Quantity |
| Each uncoated tablet contains : |
|
|
Ondansetron Hydrochloride (eq. to Ondansetron) |
I.P. |
8 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 188 |
Tablets |
Ondansetron Orally Disintegrating Tablets I.P. 4 mg |
| Composition |
Standard |
Quantity |
| Each uncoated tablet contains : |
|
|
Ondansetron Hydrochloride (eq. to Ondansetron) |
I.P. |
4 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 189 |
Tablets |
Sildenafil Citrate Tablets I.P. 100 mg |
| Composition |
Standard |
Quantity |
| Each film-coated tablet contains : |
|
|
Sildenafil Citrate (eq. to Sildenafil) |
I.P. |
100 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 190 |
Tablets |
Paracetamol and Nimesulide Tablets (Not to be used for children below 12 years of age) |
| Composition |
Standard |
Quantity |
| Each uncoated tablet contains : |
|
|
| Paracetamol |
I.P. |
325 mg |
| Nimesulide |
B.P. |
100 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 191 |
Tablets |
Roxithromycin Tablets I.P. 150 mg |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains : |
|
|
| Roxithromycin |
I.P. |
150 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 192 |
Tablets |
Deflazacort Tablets |
| Composition |
Standard |
Quantity |
| Each uncoated tablet contains : |
|
|
| Deflazacort |
— |
30 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 193 |
Tablets |
Deflazacort Tablets |
| Composition |
Standard |
Quantity |
| Each uncoated tablet contains : |
|
|
| Deflazacort |
— |
6 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 194 |
Tablets |
Rabeprazole Gastro-resistant Tablets I.P. 20mg |
| Composition |
Standard |
Quantity |
| Each enteric coated tablet contains : |
|
|
| Rabeprazole Sodium |
I.P. |
20 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 195 |
Tablets |
Ofloxacin & Ornidazole Tablets I.P |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains : |
|
|
| Ofloxacin |
I.P. |
200 mg |
| Ornidazole |
I.P. |
500 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 196 |
Tablets |
Levofloxacin Tablets I.P. 750 mg |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains: |
|
|
Levofloxacin Hemihydrate (eq. to Levofloxacin) |
I.P. |
750 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 197 |
Tablets |
Levofloxacin Tablets I.P. 500 mg |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains: |
|
|
Levofloxacin Hemihydrate (eq. to Levofloxacin) |
I.P. |
500 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 198 |
Tablets |
Levofloxacin Tablets I.P. 250 mg |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains: |
|
|
Levofloxacin Hemihydrate (eq. to Levofloxacin) |
I.P. |
250 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 199 |
Tablets |
Pregabalin, Nortriptyline & Mecobalamin Tablets |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains: |
|
|
| Pregabalin |
I.P. |
75 mg |
Nortriptyline Hydrochloride (Eq. to Nortriptyline) |
I.P. |
10 mg |
| Mecobalamin |
I.P. |
1500 mcg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 200 |
Tablets |
Azithromycin & Lactic Acid Bacillus Tablets |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains: |
|
|
Azithromycin Dihydrate (eq. to Azithromycin anhydrous) |
I.P. |
500 mg |
| Lactic Acid Bacillus |
— |
60 Million Spores |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 201 |
Tablets |
Ferrous Ascorbate, Cyanocobalamin, Folic Acid, Zinc Sulphate Monohydrate Tablets |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains: |
|
|
| Ferrous Ascorbate |
— |
100 mg |
| Cyanocobalamin |
I.P. |
15 mcg |
| Folic Acid |
I.P. |
1.5 mg |
Zinc Sulphate Monohydrate (eq. to Elemental Zinc) |
I.P. |
22.5 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 202 |
Tablets |
Ofloxacin Tablets I.P. |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains: |
|
|
| Ofloxacin |
I.P. |
200 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 203 |
Tablets |
Pregabalin (SR) and Methylcobalamin Tablets |
| Composition |
Standard |
Quantity |
| Each uncoated tablet contains: |
|
|
| Pregabalin (Sustained Release) |
I.P. |
75 mg |
| Methylcobalamin |
I.P. |
1500 mcg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 204 |
Tablets |
Calcium Citrate, Zinc,Vitamin D3 and Magnesium Tablets |
| Composition |
Standard |
Quantity |
| Each uncoated tablet contains: |
|
|
| Calcium Citrate |
USP |
1000 mg |
Zinc Sulphate Monohydrate eq. to Elemental Zinc |
I.P. |
4 mg |
| Vitamin D3 |
I.P. |
200 IU |
Magnesium Hydroxide eq. to Elemental Magnesium |
I.P. |
100 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 205 |
Tablets |
Gabapentin and Methylcobalamin Tablets |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains: |
|
|
| Gabapentin |
I.P. |
300 mg |
| Methylcobalamin |
I.P. |
500 mcg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 206 |
Tablets |
Azithromycin Tablets I.P. |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains: |
|
|
Azithromycin Dihydrate (eq. to Azithromycin Anhydrous) |
I.P. |
500 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 207 |
Tablets |
Azithromycin Tablets I.P. |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains: |
|
|
Azithromycin Dihydrate (eq. to Azithromycin Anhydrous) |
I.P. |
250 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 208 |
Tablets |
Ferrous Ascorbate, Folic acid and Zinc Sulphate Monohydrate Tablets |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains: |
|
|
Ferrous Ascorbate (eq. to Elemental Iron) |
— |
100 mg |
| Folic Acid |
I.P. |
1.5 mg |
Zinc Sulphate Monohydrate (eq. to Elemental Zinc) |
I.P. |
22.5 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 209 |
Tablets |
Aceclofenac, Paracetamol and Thiocolchicoside Tablets |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains: |
|
|
| Aceclofenac |
I.P. |
100 mg |
| Paracetamol |
I.P. |
325 mg |
| Thiocolchicoside |
I.P. |
4 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 210 |
Tablets |
Ursodeoxycholic Acid Tablets |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains: |
|
|
| Ursodeoxycholic Acid |
I.P. |
300 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 211 |
Tablets |
Aceclofenac, Paracetamol and Serratiopeptidase Tablets (Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes) |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains: |
|
|
| Aceclofenac |
I.P. |
100 mg |
| Paracetamol |
I.P. |
325 mg |
Serratiopeptidase
(eq. to enzymatic activity 20,000 units)
(as enteric coated granules)
|
I.P. |
10 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 212 |
Tablets |
Aceclofenac, Paracetamol and Serratiopeptidase Tablets (Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes) |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains: |
|
|
| Aceclofenac |
I.P. |
100 mg |
| Paracetamol |
I.P. |
325 mg |
Serratiopeptidase
(eq. to enzymatic activity 30,000 units)
(as enteric coated granules)
|
I.P. |
15 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 213 |
Tablets |
Aceclofenac, Paracetamol and Chlorzoxazone Tablets (Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes) |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains: |
|
|
| Aceclofenac |
I.P. |
100 mg |
| Paracetamol |
I.P. |
325 mg |
| Chlorzoxazone |
U.S.P. |
250 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 214 |
Tablets |
Aceclofenac and Paracetamol Tablets |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains: |
|
|
| Aceclofenac |
I.P. |
100 mg |
| Paracetamol |
I.P. |
325 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 215 |
Tablets |
Aceclofenac and Thiocolchicoside Tablets |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains: |
|
|
| Aceclofenac |
I.P. |
100 mg |
| Thiocolchicoside |
I.P. |
4 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 216 |
Tablets |
Telmisartan and Amlodipine Besilate Tablets I.P |
| Composition |
Standard |
Quantity |
| Each uncoated tablet contains: |
|
|
| Telmisartan |
I.P. |
40 mg |
| Amlodipine Besilate eq. to Amlodipine |
I.P. |
5 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 217 |
Tablets |
Etoricoxib and Thiocolchicoside Tablets |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains: |
|
|
| Etoricoxib |
I.P. |
60 mg |
| Thiocolchicoside |
I.P. |
4 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 218 |
Tablets |
Montelukast and Levocetirizine Tablets I.P |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains: |
|
|
| Montelukast Sodium eq. to Montelukast |
I.P. |
10 mg |
| Levocetirizine Hydrochloride |
I.P. |
5 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 219 |
Tablets |
Alpha Lipoic Acid, Folic Acid, Methylcobalamin, Pyridoxine HCl and Vitamin D3 Tablets |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains: |
|
|
| Alpha Lipoic Acid |
USP |
100 mg |
| Folic Acid |
I.P |
1.5 mg |
| Methylcobalamin |
I.P |
1500 mcg |
| Pyridoxine Hydrochloride |
I.P |
3 mg |
| Vitamin D3 |
I.P |
1000 IU |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 220 |
Tablets |
Paracetamol, Phenylephrine HCl, Diphenhydramine HCl and Caffeine Tablets |
| Composition |
Standard |
Quantity |
| Each chewable film-coated tablet contains : |
|
|
| Fexofenadine Hydrochloride |
I.P. |
120 mg |
| Montelukast Sodium eq. to Montelukast |
I.P. |
10 mg |
| Excipients |
q.s. |
|
| Approved Colour used |
|
|
|
| 221 |
Tablets |
Levetiracetam Tablets I.P 500 mg |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains: |
|
|
| Levetiracetam |
I.P |
500 mg |
| Excipients |
— |
q.s. |
| Approved colour used |
— |
— |
|
| 222 |
Tablets |
Ketoconazole Tablets I.P 200mg |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains: |
|
|
| Ketoconazole |
I.P |
200 mg |
| Excipients |
— |
q.s. |
| Approved colour used |
— |
— |
|
| 223 |
Tablets |
Aceclofenac & Drotaverine HCl Tablets |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains: |
|
|
| Aceclofenac |
I.P |
100 mg |
| Drotaverine Hydrochloride |
I.P |
80 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 224 |
Tablets |
Etodolac and Paracetamol Tablets |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains: |
|
|
| Etodolac |
I.P |
400 mg |
| Paracetamol |
I.P |
325 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 225 |
Tablets |
Amisulpiride Tablets I.P 100 mg |
| Composition |
Standard |
Quantity |
| Each film coated tablet contains: |
|
|
| Amisulpride |
I.P |
100 mg |
| Excipients |
— |
q.s. |
| Approved colour used |
— |
— |
|
| 226 |
Tablets |
Etodolac ER Tablets 400MG |
| Composition |
Standard |
Quantity |
| Each film coated extended release tablet contains: |
|
|
| Etodolac |
I.P |
400 mg |
| Excipients |
— |
q.s. |
| Approved Colour used |
— |
— |
|
| 227 |
Tablets |
Nimesulide Tablets (Not to be used for children below 12 years of age) |
| Composition |
Standard |
Quantity |
| Each uncoated tablet contains : |
|
|
| Nimesulide |
B.P. |
100 mg |
| Excipients |
q.s. |
|
| Approved Colour used |
|
|
|